Recent evidence has supported systemic tumor-associated inflammatory response markers, including C-reactive protein (CRP) and the Glasgow prognosis score (GPS) as able to predict the outcome in ESCC patients treated with surgery [5, 6]. This evidence concerns the gene CRP and esophageal squamous cell carcinoma.